GEO-PHARM
0667.520.049 · rovalta.com · 07/11/2026
ACTIVE
GEO-PHARM
Financial year 2025 · Closed on 31/12/2025
Net result59,3 k €-52,5 %over 1 year
Gross margin117,6 k €-41,4 %over 1 year
Equity477,8 k €+14,2 %over 1 year
Overview
Identity
Source · BCE/KBOGEO-PHARM is a Private limited company incorporated in 2016. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Uccle.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0667.520.049
- Incorporation
- 07/12/2016
- Legal form
- Private limited company
- Registered office
- Avenue Kersbeek 308
1180 Uccle · BruxellesSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 10 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 117,6 k € | -41.4% | 200,7 k € | +122% | 90,6 k € | -27.4% | 124,8 k € | +15.3% | 108,3 k € |
| EBITDA | 116,3 k € | -41.7% | 199,6 k € | +129% | 87,1 k € | -27.2% | 119,7 k € | +11.4% | 107,4 k € |
| Operating result | 106,6 k € | -44.0% | 190,4 k € | +140% | 79,5 k € | -32.4% | 117,7 k € | +13.8% | 103,4 k € |
| Net result | 59,3 k € | -52.5% | 124,8 k € | +114% | 58,4 k € | -33.3% | 87,5 k € | +14.7% | 76,3 k € |
| Balance sheet | |||||||||
| Equity | 477,8 k € | +14.2% | 418,4 k € | +42.5% | 293,6 k € | +24.8% | 235,2 k € | +59.2% | 147,7 k € |
| Total assets | 499 k € | +4.1% | 479,2 k € | +27.2% | 376,8 k € | +46.5% | 257,3 k € | +59.2% | 161,6 k € |
| Cash | 79,5 k € | +280% | 20,9 k € | -49.2% | 41,2 k € | -11.7% | 46,6 k € | -50.0% | 93,1 k € |
| Debts | 21,3 k € | -65.0% | 60,8 k € | -19.5% | 75,6 k € | +271% | 20,4 k € | +85.7% | 11 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Brigitte Thewys | Directorsince 20/10/2022Manager2018 accountsended | ||
Damien Thiéry | Directorsince 20/10/2022Manager2023 accountsendedAdministrator - manager2022 accountsended |
Other companies at this address
Avenue Kersbeek 308 1180 Uccle| Company | CBE no. |
|---|---|
2 B Kitchens● Judicial reorganisation | 1005.467.752 |
4V Construct● Bankrupt | 0651.584.236 |
AB IMPEX● Bankrupt | 0708.909.553 |
ABK TEAM● Active | 1015.781.525 |
ACE● Active | 0477.347.490 |
ACTRA● Active | 0450.637.650 |
ADGROS● Active | 0840.615.460 |
ADSCALE TECHNOLOGIES● Active | 0803.161.384 |
AF CORP● Bankrupt | 1003.452.132 |
AFT RENOV● Active | 1013.893.290 |
AGL-ALLIANCE GENERAL LOGISTICS● Active | 0555.690.234 |
AG-S● Bankrupt | 0772.986.466 |
AH PROJECT● Active | 0649.729.853 |
A.I.J● Active | 1041.094.961 |
AKB Consulting group● Active | 0742.828.275 |
AKERRAGEREAU● Active | 0690.567.051 |
A.KJÆRBEDE BE● Active | 1043.304.779 |
AKORA● Active | 1030.545.915 |
ALBION COMMUNICATION● Active | 0864.000.873 |
ALBL● Active | 0797.742.549 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 27/08/2025 | 28/04/2025 | 31/10/2023 | 15/11/2022 | 24/09/2021 |
| General meeting | 01/06/2026 | 02/06/2025 | 23/04/2025 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 01/06/2026 | 31/08/2026 | French | |
| Micro model | 31/12/2024 | 02/06/2025 | 27/08/2025 | French | |
| Micro modelCorrection | 31/12/2023 | 23/04/2025 | 28/04/2025 | French | |
| Micro model | 31/12/2023 | 30/06/2024 | 29/11/2024 | French | |
| Micro model | 31/12/2022 | 30/06/2023 | 31/10/2023 | French | |
| Micro model | 31/12/2021 | 30/06/2022 | 15/11/2022 | French | |
| Micro model | 31/12/2020 | 30/06/2021 | 24/09/2021 | French | |
| Micro model | 31/12/2019 | 30/06/2020 | 30/10/2020 | French | |
| Micro model | 31/12/2018 | 03/06/2019 | 16/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 04/06/2018 | 13/08/2018 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Brigitte Thewys | Directorsince 20/10/2022Manager2018 accountsended | ||
Damien Thiéry | Directorsince 20/10/2022Manager2023 accountsendedAdministrator - manager2022 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings9 filings
Mandates
Brigitte Thewys
Damien Thiéry
20162017201820192020202120222023202420252026
GEO-PHARM
Avenue Kersbeek 308, 1180 Uccle
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Kersbeek 308, 1180 UccleCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00467957 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| GEO-PHARMCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00467957 |
Events
- 2025Annual accounts 202559,3 k €↓
- 2024Annual accounts 2024124,8 k €↑
- 2023Annual accounts 202358,4 k €↓
- 2022Annual accounts 202287,5 k €↑
- 2021Annual accounts 202176,3 k €↑
- 2020Annual accounts 202068,9 k €↑
- 2019Annual accounts 2019-2,6 k €↓
- 2018Annual accounts 2018
- 2017Annual accounts 2017-1,1 k €
- 07/12/2016IncorporationPrivate limited company